Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT

Clinical trial NCT05530785 · UNKNOWN

Trial details

NCT number: NCT05530785
Sponsor: Yongchang Zhang
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Non-resectable

Start date: 2022-08-01
Primary completion: 2024-10-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.